APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ampicillin Sodium and Sulbactam Sodium For Injection

Compare research editions
View pricing & licenses

Selected research

Industry Research

Ampicillin Sodium and Sulbactam Sodium For Injection Industry Research Report 2026

1 January 2026116 pages

Choose your research edition.

Industry ResearchAmpicillin Sodium and Sulbactam Sodium For Injection Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Ampicillin Sodium and Sulbactam Sodium For Injection Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Ampicillin Sodium and Sulbactam Sodium For Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ampicillin Sodium and Sulbactam Sodium For Injection Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Ampicillin Sodium and Sulbactam Sodium For Injection Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Ampicillin Sodium and Sulbactam Sodium For Injection market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Ampicillin Sodium and Sulbactam Sodium For Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Ampicillin Sodium and Sulbactam Sodium For Injection is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Ampicillin Sodium and Sulbactam Sodium For Injection is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Ampicillin Sodium and Sulbactam Sodium For Injection include Hikma Pharmaceuticals, Chengdu Beite Pharmaceutical Co. Ltd, Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd., Pfizer, Jiangsu Haihong Pharmaceutical Co. Ltd, Mylan, Ruiyang Pharmaceutical Co., Ltd., Shandong Lukang Pharmaceutical Co., Ltd. and Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Ampicillin Sodium and Sulbactam Sodium For Injection market in terms of revenue (US$ million) and, where applicable, sales volume (K Doses), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Doses) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Ampicillin Sodium and Sulbactam Sodium For Injection Market by Company

Hikma Pharmaceuticals

Chengdu Beite Pharmaceutical Co. Ltd

Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd.

Pfizer

Jiangsu Haihong Pharmaceutical Co. Ltd

Mylan

Ruiyang Pharmaceutical Co., Ltd.

Shandong Lukang Pharmaceutical Co., Ltd.

Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd.

Ampicillin Sodium and Sulbactam Sodium For Injection Segment by Type

0.75g/Dose

3.0g/Dose

Ampicillin Sodium and Sulbactam Sodium For Injection Segment by Application

Urinary Tract Infection

Lower Respiratory Tract Infection

Otitis Media

Others

Ampicillin Sodium and Sulbactam Sodium For Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ampicillin Sodium and Sulbactam Sodium For Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ampicillin Sodium and Sulbactam Sodium For Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ampicillin Sodium and Sulbactam Sodium For Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Ampicillin Sodium and Sulbactam Sodium For Injection manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Ampicillin Sodium and Sulbactam Sodium For Injection by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Ampicillin Sodium and Sulbactam Sodium For Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Ampicillin Sodium and Sulbactam Sodium For Injection Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Ampicillin Sodium and Sulbactam Sodium For Injection Sales (K Doses) of Manufacturers (2021-2026) Table 7. Global Ampicillin Sodium and Sulbactam Sodium For Injection Sales Market Share by Manufacturers (2021-2026) Table 8. Global Ampicillin Sodium and Sulbactam Sodium For Injection Revenue of Manufacturers (2021-2026) Table 9. Global Ampicillin Sodium and Sulbactam Sodium For Injection Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Ampicillin Sodium and Sulbactam Sodium For Injection Average Price (US$/Dose) of Manufacturers (2021-2026) Table 11. Global Ampicillin Sodium and Sulbactam Sodium For Injection Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Ampicillin Sodium and Sulbactam Sodium For Injection, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Ampicillin Sodium and Sulbactam Sodium For Injection, Product Type & Application Table 14. Global Ampicillin Sodium and Sulbactam Sodium For Injection Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Ampicillin Sodium and Sulbactam Sodium For Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Hikma Pharmaceuticals Company Information Table 19. Hikma Pharmaceuticals Business Overview Table 20. Hikma Pharmaceuticals Ampicillin Sodium and Sulbactam Sodium For Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 21. Hikma Pharmaceuticals Ampicillin Sodium and Sulbactam Sodium For Injection Product Portfolio Table 22. Hikma Pharmaceuticals Recent Developments Table 23. Chengdu Beite Pharmaceutical Co. Ltd Company Information Table 24. Chengdu Beite Pharmaceutical Co. Ltd Business Overview Table 25. Chengdu Beite Pharmaceutical Co. Ltd Ampicillin Sodium and Sulbactam Sodium For Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 26. Chengdu Beite Pharmaceutical Co. Ltd Ampicillin Sodium and Sulbactam Sodium For Injection Product Portfolio Table 27. Chengdu Beite Pharmaceutical Co. Ltd Recent Developments Table 28. Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Company Information Table 29. Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Business Overview Table 30. Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Ampicillin Sodium and Sulbactam Sodium For Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 31. Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Ampicillin Sodium and Sulbactam Sodium For Injection Product Portfolio Table 32. Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Recent Developments Table 33. Pfizer Company Information Table 34. Pfizer Business Overview Table 35. Pfizer Ampicillin Sodium and Sulbactam Sodium For Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 36. Pfizer Ampicillin Sodium and Sulbactam Sodium For Injection Product Portfolio Table 37. Pfizer Recent Developments Table 38. Jiangsu Haihong Pharmaceutical Co. Ltd Company Information Table 39. Jiangsu Haihong Pharmaceutical Co. Ltd Business Overview Table 40. Jiangsu Haihong Pharmaceutical Co. Ltd Ampicillin Sodium and Sulbactam Sodium For Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 41. Jiangsu Haihong Pharmaceutical Co. Ltd Ampicillin Sodium and Sulbactam Sodium For Injection Product Portfolio Table 42. Jiangsu Haihong Pharmaceutical Co. Ltd Recent Developments Table 43. Mylan Company Information Table 44. Mylan Business Overview Table 45. Mylan Ampicillin Sodium and Sulbactam Sodium For Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 46. Mylan Ampicillin Sodium and Sulbactam Sodium For Injection Product Portfolio Table 47. Mylan Recent Developments Table 48. Ruiyang Pharmaceutical Co., Ltd. Company Information Table 49. Ruiyang Pharmaceutical Co., Ltd. Business Overview Table 50. Ruiyang Pharmaceutical Co., Ltd. Ampicillin Sodium and Sulbactam Sodium For Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 51. Ruiyang Pharmaceutical Co., Ltd. Ampicillin Sodium and Sulbactam Sodium For Injection Product Portfolio Table 52. Ruiyang Pharmaceutical Co., Ltd. Recent Developments Table 53. Shandong Lukang Pharmaceutical Co., Ltd. Company Information Table 54. Shandong Lukang Pharmaceutical Co., Ltd. Business Overview Table 55. Shandong Lukang Pharmaceutical Co., Ltd. Ampicillin Sodium and Sulbactam Sodium For Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 56. Shandong Lukang Pharmaceutical Co., Ltd. Ampicillin Sodium and Sulbactam Sodium For Injection Product Portfolio Table 57. Shandong Lukang Pharmaceutical Co., Ltd. Recent Developments Table 58. Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd. Company Information Table 59. Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd. Business Overview Table 60. Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd. Ampicillin Sodium and Sulbactam Sodium For Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 61. Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd. Ampicillin Sodium and Sulbactam Sodium For Injection Product Portfolio Table 62. Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd. Recent Developments Table 63. Global Ampicillin Sodium and Sulbactam Sodium For Injection Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 64. Global Ampicillin Sodium and Sulbactam Sodium For Injection Sales by Region (2021-2026) & (K Doses) Table 65. Global Ampicillin Sodium and Sulbactam Sodium For Injection Sales Market Share by Region (2021-2026) Table 66. Global Ampicillin Sodium and Sulbactam Sodium For Injection Sales by Region (2027-2032) & (K Doses) Table 67. Global Ampicillin Sodium and Sulbactam Sodium For Injection Sales Market Share by Region (2027-2032) Table 68. Global Ampicillin Sodium and Sulbactam Sodium For Injection Revenue by Region (2021-2026) & (US$ Million) Table 69. Global Ampicillin Sodium and Sulbactam Sodium For Injection Revenue Market Share by Region (2021-2026) Table 70. Global Ampicillin Sodium and Sulbactam Sodium For Injection Revenue by Region (2027-2032) & (US$ Million) Table 71. Global Ampicillin Sodium and Sulbactam Sodium For Injection Revenue Market Share by Region (2027-2032) Table 72. North America Ampicillin Sodium and Sulbactam Sodium For Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 73. North America Ampicillin Sodium and Sulbactam Sodium For Injection Sales by Country (2021-2026) & (K Doses) Table 74. North America Ampicillin Sodium and Sulbactam Sodium For Injection Sales by Country (2027-2032) & (K Doses) Table 75. North America Ampicillin Sodium and Sulbactam Sodium For Injection Revenue by Country (2021-2026) & (US$ Million) Table 76. North America Ampicillin Sodium and Sulbactam Sodium For Injection Revenue by Country (2027-2032) & (US$ Million) Table 77. Europe Ampicillin Sodium and Sulbactam Sodium For Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 78. Europe Ampicillin Sodium and Sulbactam Sodium For Injection Sales by Country (2021-2026) & (K Doses) Table 79. Europe Ampicillin Sodium and Sulbactam Sodium For Injection Sales by Country (2027-2032) & (K Doses) Table 80. Europe Ampicillin Sodium and Sulbactam Sodium For Injection Revenue by Country (2021-2026) & (US$ Million) Table 81. Europe Ampicillin Sodium and Sulbactam Sodium For Injection Revenue by Country (2027-2032) & (US$ Million) Table 82. Asia Pacific Ampicillin Sodium and Sulbactam Sodium For Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 83. Asia Pacific Ampicillin Sodium and Sulbactam Sodium For Injection Sales by Country (2021-2026) & (K Doses) Table 84. Asia Pacific Ampicillin Sodium and Sulbactam Sodium For Injection Sales by Country (2027-2032) & (K Doses) Table 85. Asia Pacific Ampicillin Sodium and Sulbactam Sodium For Injection Revenue by Country (2021-2026) & (US$ Million) Table 86. Asia Pacific Ampicillin Sodium and Sulbactam Sodium For Injection Revenue by Country (2027-2032) & (US$ Million) Table 87. South America Ampicillin Sodium and Sulbactam Sodium For Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 88. South America Ampicillin Sodium and Sulbactam Sodium For Injection Sales by Country (2021-2026) & (K Doses) Table 89. South America Ampicillin Sodium and Sulbactam Sodium For Injection Sales by Country (2027-2032) & (K Doses) Table 90. South America Ampicillin Sodium and Sulbactam Sodium For Injection Revenue by Country (2021-2026) & (US$ Million) Table 91. South America Ampicillin Sodium and Sulbactam Sodium For Injection Revenue by Country (2027-2032) & (US$ Million) Table 92. Middle East and Africa Ampicillin Sodium and Sulbactam Sodium For Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 93. Middle East and Africa Ampicillin Sodium and Sulbactam Sodium For Injection Sales by Country (2021-2026) & (K Doses) Table 94. Middle East and Africa Ampicillin Sodium and Sulbactam Sodium For Injection Sales by Country (2027-2032) & (K Doses) Table 95. Middle East and Africa Ampicillin Sodium and Sulbactam Sodium For Injection Revenue by Country (2021-2026) & (US$ Million) Table 96. Middle East and Africa Ampicillin Sodium and Sulbactam Sodium For Injection Revenue by Country (2027-2032) & (US$ Million) Table 97. Global Ampicillin Sodium and Sulbactam Sodium For Injection Sales by Type (2021-2026) & (K Doses) Table 98. Global Ampicillin Sodium and Sulbactam Sodium For Injection Sales by Type (2027-2032) & (K Doses) Table 99. Global Ampicillin Sodium and Sulbactam Sodium For Injection Sales Market Share by Type (2021-2026) Table 100. Global Ampicillin Sodium and Sulbactam Sodium For Injection Sales Market Share by Type (2027-2032) Table 101. Global Ampicillin Sodium and Sulbactam Sodium For Injection Revenue by Type (2021-2026) & (US$ Million) Table 102. Global Ampicillin Sodium and Sulbactam Sodium For Injection Revenue by Type (2027-2032) & (US$ Million) Table 103. Global Ampicillin Sodium and Sulbactam Sodium For Injection Revenue Market Share by Type (2021-2026) Table 104. Global Ampicillin Sodium and Sulbactam Sodium For Injection Revenue Market Share by Type (2027-2032) Table 105. Global Ampicillin Sodium and Sulbactam Sodium For Injection Price by Type (2021-2026) & (US$/Dose) Table 106. Global Ampicillin Sodium and Sulbactam Sodium For Injection Price by Type (2027-2032) & (US$/Dose) Table 107. Global Ampicillin Sodium and Sulbactam Sodium For Injection Sales by Application (2021-2026) & (K Doses) Table 108. Global Ampicillin Sodium and Sulbactam Sodium For Injection Sales by Application (2027-2032) & (K Doses) Table 109. Global Ampicillin Sodium and Sulbactam Sodium For Injection Sales Market Share by Application (2021-2026) Table 110. Global Ampicillin Sodium and Sulbactam Sodium For Injection Sales Market Share by Application (2027-2032) Table 111. Global Ampicillin Sodium and Sulbactam Sodium For Injection Revenue by Application (2021-2026) & (US$ Million) Table 112. Global Ampicillin Sodium and Sulbactam Sodium For Injection Revenue by Application (2027-2032) & (US$ Million) Table 113. Global Ampicillin Sodium and Sulbactam Sodium For Injection Revenue Market Share by Application (2021-2026) Table 114. Global Ampicillin Sodium and Sulbactam Sodium For Injection Revenue Market Share by Application (2027-2032) Table 115. Global Ampicillin Sodium and Sulbactam Sodium For Injection Price by Application (2021-2026) & (US$/Dose) Table 116. Global Ampicillin Sodium and Sulbactam Sodium For Injection Price by Application (2027-2032) & (US$/Dose) Table 117. Key Raw Materials Table 118. Raw Materials Key Suppliers Table 119. Ampicillin Sodium and Sulbactam Sodium For Injection Distributors List Table 120. Ampicillin Sodium and Sulbactam Sodium For Injection Customers List Table 121. Ampicillin Sodium and Sulbactam Sodium For Injection Industry Trends Table 122. Ampicillin Sodium and Sulbactam Sodium For Injection Industry Drivers Table 123. Ampicillin Sodium and Sulbactam Sodium For Injection Industry Restraints Table 124. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Ampicillin Sodium and Sulbactam Sodium For Injection Product Image Figure 5. Global Ampicillin Sodium and Sulbactam Sodium For Injection Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Ampicillin Sodium and Sulbactam Sodium For Injection Market Size (2021-2032) & (US$ Million) Figure 7. Global Ampicillin Sodium and Sulbactam Sodium For Injection Sales (2021-2032) & (K Doses) Figure 8. Global Ampicillin Sodium and Sulbactam Sodium For Injection Average Price (US$/Dose) & (2021-2032) Figure 9. 0.75g/Dose Product Image Figure 10. 3.0g/Dose Product Image Figure 11. Urinary Tract Infection Product Image Figure 12. Lower Respiratory Tract Infection Product Image Figure 13. Otitis Media Product Image Figure 14. Others Product Image Figure 15. Global Ampicillin Sodium and Sulbactam Sodium For Injection Revenue Share by Manufacturers in 2025 Figure 16. Global Manufacturers of Ampicillin Sodium and Sulbactam Sodium For Injection, Manufacturing Sites & Headquarters Figure 17. Global Top 5 and 10 Ampicillin Sodium and Sulbactam Sodium For Injection Players Market Share by Revenue in 2025 Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Ampicillin Sodium and Sulbactam Sodium For Injection Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 20. Global Ampicillin Sodium and Sulbactam Sodium For Injection Sales by Region in 2025 Figure 21. Global Ampicillin Sodium and Sulbactam Sodium For Injection Revenue by Region in 2025 Figure 22. North America Ampicillin Sodium and Sulbactam Sodium For Injection Market Size by Country in 2025 Figure 23. North America Ampicillin Sodium and Sulbactam Sodium For Injection Sales Market Share by Country (2021-2032) Figure 24. North America Ampicillin Sodium and Sulbactam Sodium For Injection Revenue Market Share by Country (2021-2032) Figure 25. United States Ampicillin Sodium and Sulbactam Sodium For Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Canada Ampicillin Sodium and Sulbactam Sodium For Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe Ampicillin Sodium and Sulbactam Sodium For Injection Market Size by Country in 2025 Figure 28. Europe Ampicillin Sodium and Sulbactam Sodium For Injection Sales Market Share by Country (2021-2032) Figure 29. Europe Ampicillin Sodium and Sulbactam Sodium For Injection Revenue Market Share by Country (2021-2032) Figure 30. Germany Ampicillin Sodium and Sulbactam Sodium For Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France Ampicillin Sodium and Sulbactam Sodium For Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. Ampicillin Sodium and Sulbactam Sodium For Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy Ampicillin Sodium and Sulbactam Sodium For Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Netherlands Ampicillin Sodium and Sulbactam Sodium For Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Asia Pacific Ampicillin Sodium and Sulbactam Sodium For Injection Market Size by Country in 2025 Figure 36. Asia Pacific Ampicillin Sodium and Sulbactam Sodium For Injection Sales Market Share by Country (2021-2032) Figure 37. Asia Pacific Ampicillin Sodium and Sulbactam Sodium For Injection Revenue Market Share by Country (2021-2032) Figure 38. China Ampicillin Sodium and Sulbactam Sodium For Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Japan Ampicillin Sodium and Sulbactam Sodium For Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. South Korea Ampicillin Sodium and Sulbactam Sodium For Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. India Ampicillin Sodium and Sulbactam Sodium For Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Australia Ampicillin Sodium and Sulbactam Sodium For Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. China Taiwan Ampicillin Sodium and Sulbactam Sodium For Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Southeast Asia Ampicillin Sodium and Sulbactam Sodium For Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Southeast Asia Ampicillin Sodium and Sulbactam Sodium For Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. South America Ampicillin Sodium and Sulbactam Sodium For Injection Market Size by Country in 2025 Figure 47. South America Ampicillin Sodium and Sulbactam Sodium For Injection Sales Market Share by Country (2021-2032) Figure 48. South America Ampicillin Sodium and Sulbactam Sodium For Injection Revenue Market Share by Country (2021-2032) Figure 49. Mexico Ampicillin Sodium and Sulbactam Sodium For Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Brazil Ampicillin Sodium and Sulbactam Sodium For Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Argentina Ampicillin Sodium and Sulbactam Sodium For Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Middle East and Africa Ampicillin Sodium and Sulbactam Sodium For Injection Market Size by Country in 2025 Figure 53. Middle East and Africa Ampicillin Sodium and Sulbactam Sodium For Injection Sales Market Share by Country (2021-2032) Figure 54. Middle East and Africa Ampicillin Sodium and Sulbactam Sodium For Injection Revenue Market Share by Country (2021-2032) Figure 55. Turkey Ampicillin Sodium and Sulbactam Sodium For Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Saudi Arabia Ampicillin Sodium and Sulbactam Sodium For Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. UAE Ampicillin Sodium and Sulbactam Sodium For Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Global Ampicillin Sodium and Sulbactam Sodium For Injection Sales Market Share by Type (2021-2032) Figure 59. Global Ampicillin Sodium and Sulbactam Sodium For Injection Revenue Market Share by Type (2021-2032) Figure 60. Global Ampicillin Sodium and Sulbactam Sodium For Injection Price (US$/Dose) by Type (2021-2032) Figure 61. Global Ampicillin Sodium and Sulbactam Sodium For Injection Sales Market Share by Application (2021-2032) Figure 62. Global Ampicillin Sodium and Sulbactam Sodium For Injection Revenue Market Share by Application (2021-2032) Figure 63. Global Ampicillin Sodium and Sulbactam Sodium For Injection Price (US$/Dose) by Application (2021-2032) Figure 64. Ampicillin Sodium and Sulbactam Sodium For Injection Value Chain Figure 65. Ampicillin Sodium and Sulbactam Sodium For Injection Production Mode & Process Figure 66. Direct Comparison with Distribution Share Figure 67. Distributors Profiles Figure 68. Ampicillin Sodium and Sulbactam Sodium For Injection Industry Opportunities and Challenges

Scope & coverage.

Types
  • 0.75g/Dose
  • 3.0g/Dose
Applications
  • Urinary Tract Infection
  • Lower Respiratory Tract Infection
  • Otitis Media
  • Others
Companies covered
  • Hikma Pharmaceuticals
  • Chengdu Beite Pharmaceutical Co. Ltd
  • Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd.
  • Pfizer
  • Jiangsu Haihong Pharmaceutical Co. Ltd
  • Mylan
  • Ruiyang Pharmaceutical Co., Ltd.
  • Shandong Lukang Pharmaceutical Co., Ltd.
  • Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd.

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Ampicillin Sodium and Sulbactam Sodium For Injection Market Size (2021-2032)
  4. 2.2.2 Global Ampicillin Sodium and Sulbactam Sodium For Injection Sales (2021-2032)
  5. 2.2.3 Global Ampicillin Sodium and Sulbactam Sodium For Injection Market Average Price (2021-2032)
  6. 2.3 Ampicillin Sodium and Sulbactam Sodium For Injection by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 0.75g/Dose
  9. 2.3.3 3.0g/Dose
  10. 2.4 Ampicillin Sodium and Sulbactam Sodium For Injection by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Urinary Tract Infection
  13. 2.4.3 Lower Respiratory Tract Infection
  14. 2.4.4 Otitis Media
  15. 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Ampicillin Sodium and Sulbactam Sodium For Injection Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Ampicillin Sodium and Sulbactam Sodium For Injection Sales (K Doses) of Manufacturers (2021-2026)
  3. 3.3 Global Ampicillin Sodium and Sulbactam Sodium For Injection Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Ampicillin Sodium and Sulbactam Sodium For Injection Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Ampicillin Sodium and Sulbactam Sodium For Injection Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Ampicillin Sodium and Sulbactam Sodium For Injection, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Ampicillin Sodium and Sulbactam Sodium For Injection, Product Type & Application
  8. 3.8 Global Manufacturers of Ampicillin Sodium and Sulbactam Sodium For Injection, Established Date
  9. 3.9 Global Ampicillin Sodium and Sulbactam Sodium For Injection Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Hikma Pharmaceuticals
  2. 4.1.1 Hikma Pharmaceuticals Company Information
  3. 4.1.2 Hikma Pharmaceuticals Business Overview
  4. 4.1.3 Hikma Pharmaceuticals Ampicillin Sodium and Sulbactam Sodium For Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Hikma Pharmaceuticals Ampicillin Sodium and Sulbactam Sodium For Injection Product Portfolio
  6. 4.1.5 Hikma Pharmaceuticals Recent Developments
  7. 4.2 Chengdu Beite Pharmaceutical Co. Ltd
  8. 4.2.1 Chengdu Beite Pharmaceutical Co. Ltd Company Information
  9. 4.2.2 Chengdu Beite Pharmaceutical Co. Ltd Business Overview
  10. 4.2.3 Chengdu Beite Pharmaceutical Co. Ltd Ampicillin Sodium and Sulbactam Sodium For Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Chengdu Beite Pharmaceutical Co. Ltd Ampicillin Sodium and Sulbactam Sodium For Injection Product Portfolio
  12. 4.2.5 Chengdu Beite Pharmaceutical Co. Ltd Recent Developments
  13. 4.3 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd.
  14. 4.3.1 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Company Information
  15. 4.3.2 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Business Overview
  16. 4.3.3 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Ampicillin Sodium and Sulbactam Sodium For Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Ampicillin Sodium and Sulbactam Sodium For Injection Product Portfolio
  18. 4.3.5 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Recent Developments
  19. 4.4 Pfizer
  20. 4.4.1 Pfizer Company Information
  21. 4.4.2 Pfizer Business Overview
  22. 4.4.3 Pfizer Ampicillin Sodium and Sulbactam Sodium For Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Pfizer Ampicillin Sodium and Sulbactam Sodium For Injection Product Portfolio
  24. 4.4.5 Pfizer Recent Developments
  25. 4.5 Jiangsu Haihong Pharmaceutical Co. Ltd
  26. 4.5.1 Jiangsu Haihong Pharmaceutical Co. Ltd Company Information
  27. 4.5.2 Jiangsu Haihong Pharmaceutical Co. Ltd Business Overview
  28. 4.5.3 Jiangsu Haihong Pharmaceutical Co. Ltd Ampicillin Sodium and Sulbactam Sodium For Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Jiangsu Haihong Pharmaceutical Co. Ltd Ampicillin Sodium and Sulbactam Sodium For Injection Product Portfolio
  30. 4.5.5 Jiangsu Haihong Pharmaceutical Co. Ltd Recent Developments
  31. 4.6 Mylan
  32. 4.6.1 Mylan Company Information
  33. 4.6.2 Mylan Business Overview
  34. 4.6.3 Mylan Ampicillin Sodium and Sulbactam Sodium For Injection Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Mylan Ampicillin Sodium and Sulbactam Sodium For Injection Product Portfolio
  36. 4.6.5 Mylan Recent Developments
  37. 4.7 Ruiyang Pharmaceutical Co., Ltd.
  38. 4.7.1 Ruiyang Pharmaceutical Co., Ltd. Company Information
  39. 4.7.2 Ruiyang Pharmaceutical Co., Ltd. Business Overview
  40. 4.7.3 Ruiyang Pharmaceutical Co., Ltd. Ampicillin Sodium and Sulbactam Sodium For Injection Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Ruiyang Pharmaceutical Co., Ltd. Ampicillin Sodium and Sulbactam Sodium For Injection Product Portfolio
  42. 4.7.5 Ruiyang Pharmaceutical Co., Ltd. Recent Developments
  43. 4.8 Shandong Lukang Pharmaceutical Co., Ltd.
  44. 4.8.1 Shandong Lukang Pharmaceutical Co., Ltd. Company Information
  45. 4.8.2 Shandong Lukang Pharmaceutical Co., Ltd. Business Overview
  46. 4.8.3 Shandong Lukang Pharmaceutical Co., Ltd. Ampicillin Sodium and Sulbactam Sodium For Injection Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Shandong Lukang Pharmaceutical Co., Ltd. Ampicillin Sodium and Sulbactam Sodium For Injection Product Portfolio
  48. 4.8.5 Shandong Lukang Pharmaceutical Co., Ltd. Recent Developments
  49. 4.9 Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd.
  50. 4.9.1 Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd. Company Information
  51. 4.9.2 Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd. Business Overview
  52. 4.9.3 Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd. Ampicillin Sodium and Sulbactam Sodium For Injection Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd. Ampicillin Sodium and Sulbactam Sodium For Injection Product Portfolio
  54. 4.9.5 Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd. Recent Developments
5 Global Ampicillin Sodium and Sulbactam Sodium For Injection Market Scenario by Region
  1. 5.1 Global Ampicillin Sodium and Sulbactam Sodium For Injection Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Ampicillin Sodium and Sulbactam Sodium For Injection Sales by Region: 2021-2032
  3. 5.2.1 Global Ampicillin Sodium and Sulbactam Sodium For Injection Sales by Region: 2021-2026
  4. 5.2.2 Global Ampicillin Sodium and Sulbactam Sodium For Injection Sales by Region: 2027-2032
  5. 5.3 Global Ampicillin Sodium and Sulbactam Sodium For Injection Revenue by Region: 2021-2032
  6. 5.3.1 Global Ampicillin Sodium and Sulbactam Sodium For Injection Revenue by Region: 2021-2026
  7. 5.3.2 Global Ampicillin Sodium and Sulbactam Sodium For Injection Revenue by Region: 2027-2032
  8. 5.4 North America Ampicillin Sodium and Sulbactam Sodium For Injection Market Facts & Figures by Country
  9. 5.4.1 North America Ampicillin Sodium and Sulbactam Sodium For Injection Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Ampicillin Sodium and Sulbactam Sodium For Injection Sales by Country (2021-2032)
  11. 5.4.3 North America Ampicillin Sodium and Sulbactam Sodium For Injection Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe Ampicillin Sodium and Sulbactam Sodium For Injection Market Facts & Figures by Country
  15. 5.5.1 Europe Ampicillin Sodium and Sulbactam Sodium For Injection Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe Ampicillin Sodium and Sulbactam Sodium For Injection Sales by Country (2021-2032)
  17. 5.5.3 Europe Ampicillin Sodium and Sulbactam Sodium For Injection Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.6 Asia Pacific Ampicillin Sodium and Sulbactam Sodium For Injection Market Facts & Figures by Country
  24. 5.6.1 Asia Pacific Ampicillin Sodium and Sulbactam Sodium For Injection Market Size by Country: 2021 VS 2025 VS 2032
  25. 5.6.2 Asia Pacific Ampicillin Sodium and Sulbactam Sodium For Injection Sales by Country (2021-2032)
  26. 5.6.3 Asia Pacific Ampicillin Sodium and Sulbactam Sodium For Injection Revenue by Country (2021-2032)
  27. 5.6.4 China
  28. 5.6.5 Japan
  29. 5.6.6 South Korea
  30. 5.6.7 India
  31. 5.6.8 Australia
  32. 5.6.9 China Taiwan
  33. 5.6.10 Southeast Asia
  34. 5.7 South America Ampicillin Sodium and Sulbactam Sodium For Injection Market Facts & Figures by Country
  35. 5.7.1 South America Ampicillin Sodium and Sulbactam Sodium For Injection Market Size by Country: 2021 VS 2025 VS 2032
  36. 5.7.2 South America Ampicillin Sodium and Sulbactam Sodium For Injection Sales by Country (2021-2032)
  37. 5.7.3 South America Ampicillin Sodium and Sulbactam Sodium For Injection Revenue by Country (2021-2032)
  38. 5.7.4 Mexico
  39. 5.7.5 Brazil
  40. 5.7.6 Argentina
  41. 5.8 Middle East and Africa Ampicillin Sodium and Sulbactam Sodium For Injection Market Facts & Figures by Country
  42. 5.8.1 Middle East and Africa Ampicillin Sodium and Sulbactam Sodium For Injection Market Size by Country: 2021 VS 2025 VS 2032
  43. 5.8.2 Middle East and Africa Ampicillin Sodium and Sulbactam Sodium For Injection Sales by Country (2021-2032)
  44. 5.8.3 Middle East and Africa Ampicillin Sodium and Sulbactam Sodium For Injection Revenue by Country (2021-2032)
  45. 5.8.4 Turkey
  46. 5.8.5 Saudi Arabia
  47. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global Ampicillin Sodium and Sulbactam Sodium For Injection Sales by Type (2021-2032)
  2. 6.1.1 Global Ampicillin Sodium and Sulbactam Sodium For Injection Sales by Type (2021-2032) & (K Doses)
  3. 6.1.2 Global Ampicillin Sodium and Sulbactam Sodium For Injection Sales Market Share by Type (2021-2032)
  4. 6.2 Global Ampicillin Sodium and Sulbactam Sodium For Injection Revenue by Type (2021-2032)
  5. 6.2.1 Global Ampicillin Sodium and Sulbactam Sodium For Injection Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Ampicillin Sodium and Sulbactam Sodium For Injection Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Ampicillin Sodium and Sulbactam Sodium For Injection Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Ampicillin Sodium and Sulbactam Sodium For Injection Sales by Application (2021-2032)
  2. 7.1.1 Global Ampicillin Sodium and Sulbactam Sodium For Injection Sales by Application (2021-2032) & (K Doses)
  3. 7.1.2 Global Ampicillin Sodium and Sulbactam Sodium For Injection Sales Market Share by Application (2021-2032)
  4. 7.2 Global Ampicillin Sodium and Sulbactam Sodium For Injection Revenue by Application (2021-2032)
  5. 7.2.1 Global Ampicillin Sodium and Sulbactam Sodium For Injection Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Ampicillin Sodium and Sulbactam Sodium For Injection Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Ampicillin Sodium and Sulbactam Sodium For Injection Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Ampicillin Sodium and Sulbactam Sodium For Injection Value Chain Analysis
  2. 8.1.1 Ampicillin Sodium and Sulbactam Sodium For Injection Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Ampicillin Sodium and Sulbactam Sodium For Injection Production Mode & Process
  5. 8.2 Ampicillin Sodium and Sulbactam Sodium For Injection Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Ampicillin Sodium and Sulbactam Sodium For Injection Distributors
  8. 8.2.3 Ampicillin Sodium and Sulbactam Sodium For Injection Customers
9 Global Ampicillin Sodium and Sulbactam Sodium For Injection Analyzing Market Dynamics
  1. 9.1 Ampicillin Sodium and Sulbactam Sodium For Injection Industry Trends
  2. 9.2 Ampicillin Sodium and Sulbactam Sodium For Injection Industry Drivers
  3. 9.3 Ampicillin Sodium and Sulbactam Sodium For Injection Industry Opportunities and Challenges
  4. 9.4 Ampicillin Sodium and Sulbactam Sodium For Injection Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst